
0.00
- With a market cap of N/A.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 24 07 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 24 05 2022 | Quarterly Results & Audited Results |
| 29 07 2022 | Quarterly Results |
| 20 10 2022 | Quarterly Results(Cancelled) (Cancelled) |
| 08 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 29 05 2023 | Quarterly Results & Audited Results |
| 12 08 2023 | Quarterly Results |
| 31 10 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 27 09 2024 | Fund Raising |
| 25 10 2024 | Quarterly Results |
| 13 01 2025 | Inter-alia discuss and consider raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, including by way of further public issue, right issue, DRs/ GDRs/ FCCBs, debt issue, preferential allotment, private placement, qualified institutions placement(?QIP?), or any other method as may be permitted under the applicable laws, subject to such governmental / statutory / regulatory and other approvals as may be required including the approval of the Members of the Company. |
| 11 02 2025 | Quarterly Results |
| 08 04 2025 | Inter alia, to consider and approve the proposal for fund raising through the issuance of equity shares / convertible bonds / debentures / warrants / preference shares / any other equity linked securities (?Appropriate Securities?) through permissible modes, including but not limited to a private placement, preferential issue, or any other method or combination of methods, subject to such regulatory/statutory approvals, as may be required. |
| 05 05 2025 | Audited Results |
| 29 07 2025 | Quarterly Results |
| 12 11 2025 | Quarterly Results |
| 12 02 2026 | Quarterly Results |
